References
Libutti SK, Alexander HR, Choyke P, et al. A Prospective Study of 2-[18F] Fluoro-2-Deoxy-d-glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels. Ann Surg Oncol 8: 779–86.
Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Sem Nucl Med 2000; 30: 150–85.
Willkomm P, Bender H, Bangard M, et al. FDG-PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41: 1657–63.
Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227: 319–23.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Swanson, R.S. Is an FDG-PET Scan the New Imaging Standard for Colon Cancer?. Ann Surg Oncol 8, 752–753 (2001). https://doi.org/10.1007/s10434-001-0752-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-001-0752-7